A rare inherited bone disorder called multicentric osteolysis, nodulosis, and arthropathy, or MONA, has been documented in two brothers who demonstrated marked intrafamilial phenotypic variability. The brothers, aged 14 and 8, came from a consanguineous family, and both carried the identical homozygous disease-causing variant in the MMP2 gene: c.1648 C > T, which produces the protein change p.Arg550Ter. Despite sharing the same molecular defect, the older boy developed severe foot and ankle deformities with extensive plantar nodulosis and substantial limitation of walking, while his younger brother followed a milder skeletal course but developed optic nerve involvement associated with raised intracranial pressure.
The authors then reviewed previously published MMP2 variants for phenotypic comparison.
Both brothers showed the core skeletal manifestations of the condition. Imaging and examination revealed osteopenia, progressive distal osteolysis, deformities of the hands and feet, and joint contractures. Yet the degree of involvement differed markedly between siblings.
The hepatobiliary histories of the two boys added another layer of complexity. Whether MMP2 deficiency contributed to these neonatal hepatobiliary problems remains unresolved, and the authors explicitly state that the relationship of the extraskeletal findings to MMP2 deficiency is uncertain.
An endocrine phenotype further distinguished the family’s presentation. However, only the elder brother developed this endocrine phenotype, and re-analysis of his genetic data found no pathogenic CYP21A2 variant. This combination of skeletal, hepatobiliary, endocrine, and ophthalmologic features in a single molecularly confirmed diagnosis illustrates how far the clinical picture of MONA can extend beyond bone.
The literature review that accompanied the case report examined the published spectrum of MMP2 variants and their associated phenotypes. The analysis found substantial clinical heterogeneity across reported cases. Notably, the authors conclude that neither the type of variant nor its location within the protein domain alone could predict whether a patient would develop extraskeletal manifestations.
The authors frame the brothers as evidence of marked intrafamilial phenotypic variability in MMP2-related MONA. The report calls for larger, longitudinal cohorts of molecularly confirmed patients to clarify genotype-phenotype correlations in this rare skeletal dysplasia.
Subject of Research: MMP2-related multicentric osteolysis, nodulosis, and arthropathy in two brothers with intrafamilial phenotypic variability
Article Title: Expanding the molecular and phenotypic spectrum of MMP2-related multicentric osteolysis, nodulosis, and arthropathy: two brothers with marked intrafamilial variability and a review of the literature
Article References: Hajati, R., Kamfar, S., Movafagh, A., Karimzadeh, P., Sayad, A., & Salehpour, S. (2026). Expanding the molecular and phenotypic spectrum of MMP2-related multicentric osteolysis, nodulosis, and arthropathy: two brothers with marked intrafamilial variability and a review of the literature. Molecular Biology Reports, 53(1), Article 1841. https://doi.org/10.1007/s11033-026-13024-x
Image Credits: AI Generated
DOI: 10.1007/s11033-026-13024-x
Keywords: MMP2, MONA, multicentric osteolysis, skeletal dysplasia, autosomal recessive, whole-exome sequencing, osteolysis, zoledronic acid, genotype-phenotype correlation, biliary atresia, congenital adrenal hyperplasia, optic nerve involvement
News Source: Juliet Wilcox. (November 7, 2026). Two Brothers With Same MMP2 Gene Defect Show Strikingly Different Disease Courses. Scienmag.



